Related Experiment Video
Updated: Jan 8, 2026
Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay
Published on: February 9, 2021
Structure-activity relationships reveal a 4-(2-pyridyl)chalcone as a potent cell death inducer
Juan Perdomo1, Henoc Del Rosario1, Ester Saavedra1
1Departamento de Bioquímica y Biología Molecular, Fisiología, Genética e Inmunología, Instituto Universitario de Investigaciones Biomédicas y Sanitarias (IUIBS), Grupo de Química Orgánica y Bioquímica, Universidad de Las Palmas de Gran Canaria, Unidad Asociada al Consejo Superior de Investigaciones Científicas (CSIC), 35016, Las Palmas de Gran Canaria, Spain.
New chalcone derivatives show promise as anticancer drugs. The compound 6'-benzyloxy-2'-hydroxy-4-(2-pyridyl)chalcone (BHP) effectively reduced leukaemia cell viability by inducing apoptosis, offering a potential new therapeutic strategy.
Area of Science:
- Medicinal Chemistry
- Cancer Biology
- Pharmacology
Background:
- Chalcones are natural compounds and precursors to flavonoids.
- Chalcones are being investigated as potential anticancer agents.
- Leukemia remains a significant health concern requiring novel therapeutic strategies.
Purpose of the Study:
- To synthesize and evaluate twenty-two chalcone derivatives for their anticancer activity against human leukemia cell lines.
- To identify specific structural features of chalcones that enhance their anti-leukemic effects.
- To elucidate the mechanism of action of the most potent chalcone derivative, BHP.
Main Methods:
- Synthesis of twenty-two chalcone derivatives with variations in A and B ring substituents.
- In vitro evaluation of chalcone cytotoxicity against eight human leukemia cell lines using IC50 values.
- Mechanism of action studies for the lead compound (BHP), including cell cycle analysis, apoptosis assays, western blotting, and assessment of reactive oxygen species (ROS) generation.
Main Results:
- Chalcones with a 2 étaire-benzyloxy group and halogen or 2-pyridyl substituents on the B ring demonstrated the lowest IC50 values.
- The compound 6 étaire-benzyloxy-2 étaire-hydroxy-4-(2-pyridyl)chalcone (BHP) showed potent anti-leukemic activity comparable to etoposide against U-937 cells, with reduced toxicity to normal cells.
- BHP induced apoptosis in leukemia cells via the mitochondrial pathway, involving cytochrome c release, caspase activation, and ROS generation, independent of cell cycle arrest or Bcl-2/P-glycoprotein overexpression.
Conclusions:
- Specific structural modifications of chalcones can yield potent anti-leukemic agents.
- BHP is a promising lead compound for leukemia treatment, exhibiting potent apoptosis-inducing activity through the intrinsic pathway.
- Further investigation into BHP and related chalcones could lead to the development of novel anticancer therapies.
More Related Videos
13:54Preparation of Cell-lines for Conditional Knockdown of Gene Expression and Measurement of the Knockdown Effects on E4orf4-Induced Cell Death
Published on: October 21, 2012
15:53Cell Death Associated with Abnormal Mitosis Observed by Confocal Imaging in Live Cancer Cells
Published on: August 21, 2013
Related Concept Videos
01:30Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
01:31The Intrinsic Apoptotic Pathway